-
Something wrong with this record ?
Linoleic acid inhibits lipopolysaccharide-induced inflammation by promoting TLR4 regulated autophagy in murine RAW264.7 macrophages
Y. Qin, K. Li, Q. Zhang, J. Liu, Y. Xie, T. Zhang, X. Wang, L. Zhang, Y. Jiang, G. Liu
Language English Country Czech Republic
Document type Journal Article
Grant support
2022MSXM006
Chongqing Municipal Public Health Bureau of Chongqing People - China
2023MSXM106
Graduate Innovative Special Fund Projects of Chongqing - China
CYS22385
Graduate Innovative Special Fund Projects of Chongqing - China
NLK
Directory of Open Access Journals
from 2019
ROAD: Directory of Open Access Scholarly Resources
from 2002
PubMed
40033806
DOI
10.32725/jab.2024.023
Knihovny.cz E-resources
- MeSH
- Autophagy * drug effects MeSH
- Linoleic Acid * pharmacology MeSH
- Lipopolysaccharides * toxicity MeSH
- Macrophages * drug effects metabolism immunology MeSH
- Mice MeSH
- RAW 264.7 Cells MeSH
- Sepsis chemically induced drug therapy metabolism immunology MeSH
- Signal Transduction drug effects MeSH
- Toll-Like Receptor 4 * metabolism MeSH
- Inflammation * metabolism drug therapy chemically induced pathology MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Linoleic acid (LA), an essential fatty acid, has emerged as a pivotal regulator in disorders associated with inflammation in recent years; however, the underlying mechanisms are still not completely understood. We utilized network pharmacology and experimental methodologies to elucidate the mechanisms underlying the anti-inflammatory effects of LA. Our network pharmacology analysis revealed that LA shares common targets with sepsis. These targets are enriched in various pathways comprising C-type signaling pathway, PI3K-Akt signaling pathway, toll-like receptor signaling pathway, neutrophil extracellular trap formation, AMPK signaling pathway, and autophagy-animal. These findings suggest that LA may exert regulatory effects on inflammation and autophagy during sepsis. Subsequently, we established in vivo and ex vivo models of sepsis using lipopolysaccharide (LPS) in experimental study. Treatment with LA reduced lung damage in mice with LPS-induced lung injury, and reduced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in plasma, bronchoalveolar lavage fluid (BALF), and peritoneal lavage fluid (PLF). LA also decreased the production of TNF-α and IL-6 in RAW264.7 macrophages exposed to LPS. In LPS-induced RAW264.7 macrophages, LA induced an elevation in LC3-II while causing a reduction in p62, which was associated with downregulation of toll-like receptor 4 (TLR4). We utilized 3-methyladenine (3-MA) to inhibit the autophagic activity, which reversed the modulatory effects of LA on LC3-II and p62. 3-MA also prevented the decline in TLR4 expression along with reduction in pro-inflammatory cytokines secretion. Our findings suggest that the activation of autophagy by LA may lead to the downregulation of TLR4, thereby exerting its anti-inflammatory effects.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25011856
- 003
- CZ-PrNML
- 005
- 20250521143004.0
- 007
- ta
- 008
- 250506s2024 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2024.023 $2 doi
- 035 __
- $a (PubMed)40033806
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Qin, Yin $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 245 10
- $a Linoleic acid inhibits lipopolysaccharide-induced inflammation by promoting TLR4 regulated autophagy in murine RAW264.7 macrophages / $c Y. Qin, K. Li, Q. Zhang, J. Liu, Y. Xie, T. Zhang, X. Wang, L. Zhang, Y. Jiang, G. Liu
- 520 9_
- $a Linoleic acid (LA), an essential fatty acid, has emerged as a pivotal regulator in disorders associated with inflammation in recent years; however, the underlying mechanisms are still not completely understood. We utilized network pharmacology and experimental methodologies to elucidate the mechanisms underlying the anti-inflammatory effects of LA. Our network pharmacology analysis revealed that LA shares common targets with sepsis. These targets are enriched in various pathways comprising C-type signaling pathway, PI3K-Akt signaling pathway, toll-like receptor signaling pathway, neutrophil extracellular trap formation, AMPK signaling pathway, and autophagy-animal. These findings suggest that LA may exert regulatory effects on inflammation and autophagy during sepsis. Subsequently, we established in vivo and ex vivo models of sepsis using lipopolysaccharide (LPS) in experimental study. Treatment with LA reduced lung damage in mice with LPS-induced lung injury, and reduced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in plasma, bronchoalveolar lavage fluid (BALF), and peritoneal lavage fluid (PLF). LA also decreased the production of TNF-α and IL-6 in RAW264.7 macrophages exposed to LPS. In LPS-induced RAW264.7 macrophages, LA induced an elevation in LC3-II while causing a reduction in p62, which was associated with downregulation of toll-like receptor 4 (TLR4). We utilized 3-methyladenine (3-MA) to inhibit the autophagic activity, which reversed the modulatory effects of LA on LC3-II and p62. 3-MA also prevented the decline in TLR4 expression along with reduction in pro-inflammatory cytokines secretion. Our findings suggest that the activation of autophagy by LA may lead to the downregulation of TLR4, thereby exerting its anti-inflammatory effects.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 12
- $a autofagie $x účinky léků $7 D001343
- 650 12
- $a toll-like receptor 4 $x metabolismus $7 D051197
- 650 12
- $a lipopolysacharidy $x toxicita $7 D008070
- 650 _2
- $a RAW 264.7 buňky $7 D000067996
- 650 12
- $a zánět $x metabolismus $x farmakoterapie $x chemicky indukované $x patologie $7 D007249
- 650 12
- $a kyselina linolová $x farmakologie $7 D019787
- 650 12
- $a makrofágy $x účinky léků $x metabolismus $x imunologie $7 D008264
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a sepse $x chemicky indukované $x farmakoterapie $x metabolismus $x imunologie $7 D018805
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Li, Kexin $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 700 1_
- $a Zhang, Qiuhong $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 700 1_
- $a Liu, Jie $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 700 1_
- $a Xie, Yu $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 700 1_
- $a Zhang, Tingting $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 700 1_
- $a Wang, Xiaoliang $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 700 1_
- $a Zhang, Li $u Chongqing Medical University, Department of Pathophysiology, Chongqing 400016, China
- 700 1_
- $a Jiang, Yu $u University-Town Hospital of Chongqing Medical University, Department of Respiratory and Critical Care Medicine, Chongqing 401331, China
- 700 1_
- $a Liu, Gang $u University-Town Hospital of Chongqing Medical University, Department of Emergency and Critical Care Medicine, Chongqing 401331, China $u University-Town Hospital of Chongqing Medical University, Medical Sciences Research Center, Chongqing 401331, China
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $x 1214-0287 $g Roč. 22, č. 4 (2024), s. 185-196
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40033806 $y Pubmed
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y p $z 0
- 990 __
- $a 20250506 $b ABA008
- 991 __
- $a 20250521143002 $b ABA008
- 999 __
- $a ok $b bmc $g 2324884 $s 1248946
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 22 $c 4 $d 185-196 $e 20241205 $i 1214-0287 $m Journal of applied biomedicine $n J Appl Biomed $x MED00012667
- GRA __
- $a 2022MSXM006 $p Chongqing Municipal Public Health Bureau of Chongqing People $2 China
- GRA __
- $a 2023MSXM106 $p Graduate Innovative Special Fund Projects of Chongqing $2 China
- GRA __
- $a CYS22385 $p Graduate Innovative Special Fund Projects of Chongqing $2 China
- LZP __
- $b NLK124 $a Pubmed-20250506